Capital at risk. These are high-risk investments. For certified high-net-worth and sophisticated investors only. Veles Capital Ltd is not authorised or regulated by the FCA.
← All opportunities Marketplace · AnimalTech

A welfare-first marketplace for responsible dog and horse breeding.

GenoVaq is building the trusted infrastructure layer for breeding genetics — verified breeders, standardised health data, escrow-protected payments and a free lifelong health record for every animal.

Seed£500k raiseSEIS / EIS qualifyingVeles: advisor

Visit genovaq.co.uk ↗

⚠ Don’t invest unless you’re prepared to lose all the money you invest.

This is a high-risk investment. You are unlikely to be protected if something goes wrong, your capital is at risk, returns are not guaranteed and you may not be able to exit when you want to. Take independent advice if you are unsure.

The business

What GenoVaq does

The market for breeding genetics has existed for decades; what it has lacked is a trusted, welfare-first layer that makes responsible breeding the easiest path to follow. GenoVaq is building exactly that for dogs and sports horses.

Every seller is KYC-verified with vet references on file. Listings are standardised — lineage, performance and health testing in consistent, comparable fields — and payments are held in escrow until shipment is confirmed, with a marketplace-level dispute framework behind every transaction.

Around the marketplace sit two free public tools: a Welfare Hub of plain-English buyer education, and a free lifelong health record for any owner — vaccinations, vet records and reminders, shareable with a vet by secure QR code. It is a welfare-led, science-informed business with a clear commercial model.

The raise

Opportunity at a glance

£500k

Round size

SEIS / EIS qualifying

Tax status

Seed

Stage

Advisor

Veles role

Why Veles is involved

GenoVaq pairs a genuine welfare mission with marketplace economics — verified supply, standardised data and transaction-level trust. It is SEIS/EIS qualifying, giving eligible UK investors meaningful tax reliefs, and Veles supports the team on structure and go-to-market.

Next step

Register your interest

Specific terms are shared confidentially with eligible investors. Confirm your investor status and register to find out more about GenoVaq.

Confirm status & register Contact us